Medicine by Design partners with hiring departments at the University of Toronto and affiliated hospitals to recruit established and emerging leaders in regenerative medicine.
Applications invited for Executive Director, Medicine by Design
The University of Toronto invites applications for an Executive Director to lead Medicine by Design, an integrated program of outstanding research that is a globally competitive hub for discovering, manufacturing and commercializing biologics to treat chronic and degenerative disease to improve health and create long-term economic benefits for Canadians.
The mandate of Medicine by Design is to undertake transformative research and clinical translation in regenerative medicine, enhance capability in synthetic biology and computational biology, and foster translation, commercialization and clinical impacts. MbD was jointly conceived by The Hospital for Sick Children (SickKids), University Health Network (UHN), Sinai Health System, and the Faculties of Medicine, Pharmacy, Applied Science & Engineering, and Arts & Science at the University of Toronto (U of T), and enabled by an unprecedented $114 million grant from the Canada First Research Excellence Fund in 2015. The funding allows the University and its partners to deliver new programs building on years of support for our regenerative medicine researchers, from federal granting councils, the Canada Foundation for Innovation, the Ontario Ministry of Research, Innovation and Science, and support from the Canada Research Chairs and Canada Excellence Research Chairs programs. Medicine by Design is greatly facilitated by U of T’s integrated system of specialized research facilities dedicated to basic and applied research, clinical translation, advanced manufacturing and commercialization, such as the Translational Biology and Engineering Program, a key component of the Ted Rogers Centre for Heart Research, and the Centre for Commercialization of Regenerative Medicine.
In its first two years, MbD has provided funding worth a total of over $30 million over three years to more than 100 researchers and clinicians to fast track stem cell research. The majority of funds in this first investment are focused on highly interdisciplinary team projects. In collaboration with hospitals, partners and industry, projects include research into fundamental questions in regenerative medicine, innovations that are expected to be ready for clinical trials within a few years, and enabling technologies that have the potential to accelerate discoveries across the field. A key Clinical Translation and Commercialization Fund competition was launched January 2017. Further rounds of funding will be supported to 2022.
Medicine by Design’s ambitious goal requires commitment, energy and exceptional leadership. As its scientific leader, the Executive Director will help drive a collaborative research program with accountability to an executive committee composed of the Vice-Presidents, Research from the participating hospitals and the Deans of the participating Faculties. Core duties include leadership in program delivery and review, faculty and clinician recruitment, internationalization, partnerships and collaborations, clinical translation and commercialization, knowledge mobilization and external relations, and operational and financial stewardship. Appointment as the Executive Director will be for a five-year term.
As the ideal candidate, you have a reputation befitting a researcher of global renown. You personify collaboration and excellence in research or clinical practice and knowledge translation, and bring to MbD an established record of research leadership in environments that span basic and clinical sciences. You are a skilled relationship builder, a gifted communicator and a respected representative for scientific excellence who works exceptionally well with all stakeholders, including researchers, health-care professionals, institutional leaders, government agencies, donors and the general public. The successful candidate must have an established record of scholarly achievement, and be eligible for appointment at the rank of Associate or Full Professor.
Established in 1827 by royal charter, the University of Toronto is the largest and highest-ranked research-intensive university in Canada, located in one of the world’s great cities. The University has more than 18,000 faculty and staff, some 83,000 students across three campuses, an annual budget of $2 billion, and research grant and contract support of more than $1.2 billion. Its employees, students and alumni contribute an estimated $4.4 billion directly to the economy of the Toronto region and the University is one of its largest employers. For more than a century, the University has been at the heart of building one of the world’s strongest health science networks for biomedical research, drug development, health education, health policy and clinical care. This broad network includes U of T’s health science Faculties, the Toronto Academic Health Science Network (TAHSN) nine fully affiliated teaching hospitals, four TAHSN associate member affiliates, as well as 20 community-affiliated hospitals and health-care sites across the Greater Toronto Area and beyond. For further information about the University, please visit www.utoronto.ca.
This is an exciting and unprecedented opportunity for a great researcher, a visionary leader and an outstanding manager to drive discovery and impact.
If you are interested in leading this initiative, please contact Helen Lasthiotakis, Executive Director, Office of the Vice-President, Research & Innovation, University of Toronto at 416-978-6475, or send your curriculum vitae and cover letter to us at email@example.com. Application review will begin May 30, 2017, and the position will be open until filled.
The University of Toronto is strongly committed to diversity within its community and especially welcomes applications from racialized persons / persons of colour, women, Indigenous / Aboriginal People of North America, persons with disabilities, LGBTQ persons, and others who may contribute to the further diversification of ideas.
All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.